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Abstract
Limited endoproteolysis plays a key role in the activation and maturation of proteins that 
traverse the secretory pathway. Subtilisin-like Proprotein Convertases (SPCs) are a 
family of eukaryotic endoprotease that carry out limited endoproteolysis in the secretory 
pathway. SPCs activate a diverse array of proproteins like clotting factors, enzymes, 
hormones, and also proteins involved in infectious and non-infectious diseases. SPCs 
activate proteins by recognizing a cleavage sequence generally described as N-Arg-X-X- 
Arg-C (with each amino acid designated as N-P4-P3-P2-P1-C). However, each enzyme 
has its unique substrate preferences, which likely impart particular physiological and 
pathological roles. We examined the substrate preferences of widely expressed SPCs 
(furin, PACE4, PCS, and PC7) at the P2 position of substrates, using both qualitative and 
quantitative analysis. We found that all the enzymes show a similar pattern of substrate 
preferences, but at the same time they also have unique characteristics. Furin at pH 6.0 
showed a broader range of substrate preferences than at pH 7.0. PACE4 showed stringent 
substrate specificity at P2 position. PC7 was less efficient over the entire range of 
substrates. To understand which amino acids might make PACE4 different from furin, we
examined the S2 subsite (amino acids in the enzyme interacting with the P2 position in 
substrates) of PACE4 by creating three mutants called E94D, D90T, DM. The results of 
D90T suggest that aspartic acid at position 90 of PACE4 helps mediate P2 sequence 
requirements. Qualitative results did not necessarily agree with the quantitative results 
likely because o f overall change in the structural conformation of the substrate proteins.
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Introduction
Discovery of Subtilisin-like Proprotein Convertases
In organisms from yeast to mammals, a broad spectrum of biologically 
important peptides and proteins are synthesized as higher molecular mass 
precursors. These are post-translationally converted into biologically active forms 
by cleavage, typically at sites formed by doublets or clusters o f basic amino acids. 
This limited endoproteolysis o f precursor proteins is a common mechanism for 
production of functional proteins and peptides that traverse the secretory pathway 
(1-3). Endoproteases are the enzymes that hydrolyze peptide and protein 
substrates at these specific internal peptide bonds (4).
The Kex2 protease [Kex2p; also referred to as kexin (EC 3.4.21.61)] of 
Saccharomyces cerevisiae was the first o f the eukaryotic secretory system 
endoproteases to be discovered. Kex2p is a Ca2+-dependent, neutral serine 
protease with a subtilisin-like catalytic domain that is involved in processing pro­
a-mating factor and pro-killer toxin (5-6). Kex2p is a membrane-bound 
glycoprotein localized in Trans Golgi Network (TGN) (5).
The first mammalian homolog of Kex2p was discovered by Fuller et al. in 
1989 by a search of sequence databases. The gene identified was designated fur, 
which got its name from c-/esIfps upstream region. Fur coded for a protein, 
named Furin, highly similar to Kex2p in the subtilisin-like catalytic domain and
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its flanking regions (7). Furin is now known to be one member of a class of 
related endoproteases.
Subtilisin like Proprotein Convertases (SPC’s)
PCR-based strategies have identified additional members of the 
mammalian subtilisin/Kex2p family, namely PC1/PC3 (Prohormone or Proprotein 
Convertase 1), PC2, PC4, PC5/PC6, PC7/PC8/SPC7/LPC (Lymphoma Proprotein 
Convertase) and PACE4 (Paired Basic Amino Acid Cleaving Enzyme 4). Two 
more distantly related endoproteases, called SKI-1/SfP (Subtilisin Kexin 
isoenzyme-1/ site-1 protease) and NARC-1/ PCSK9 (Neural apoptosis-regulated 
convertase-1 /Proprotein convertase subtilisin-Kexin like-9) have also been 
discovered (8). Because of their subtilisin-like catalytic domain, these proteases 
are collectively called Subtilisin-like Proprotein Convertases, or SPCs (4, 7, 9, 
and 10). Kex2p counterparts have also been identified in many non-mammalian 
eukaryotes (7).
Tissue Distribution
On the basis of their tissue distribution the mammalian proprotein 
convertases can be classified into two groups. Furin, PACE4, PC5/PC6, 
LPC/PC7/PC8/SPC7 and SKI-1 /SIP are expressed in a broad range of tissues and 
cell lines. Expression of PC2, PC1/PC3, PC4 and NARC-1/PCSK9 is tissue 
specific (7, 11). Among these enzymes, PACE4, PC4 and PC5/PC6 have isoforms 
that are generated via alternative splicing of the same primary transcripts. PC6
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occurs in two isoforms; PC6A, which has been found in a variety o f tissues and 
cell lines, and PC6B, which has a much larger cysteine-rich region than PC6A 
and has been found mainly in intestine (12).
Structural Organization
The structural organization of the SPCs appears to be highly similar and 
contains common features. One common feature of all these enzymes is that they 
are synthesized as zymogens, with multiple basic residues often seen at the 
presumed maturation cleavage site. Typically, the propeptide is autocatalytically 
removed through cleavage at the aforementioned multibasic site during 
maturation of the convertases. The catalytic domain of proprotein convertases 
typically extends over 330 amino acids and is highly conserved among all 
members o f the family. The active-site residues Asp, His and Ser are the catalytic 
triad and are universally conserved. An Asn residue, which stabilizes the 
oxyanion hole in the reaction transitional state, is present at corresponding 
positions in all members except for PC2, where the Asn residue is replaced by an 
Asp. The sequences flanking these residues are highly conserved as well.
Following the catalytic domain is a 140-amino-acid region that has been 
referred to as the 'Homo B', 'P ' or ’middle' domain. This domain is also well 
conserved among eukaryotic convertases, including Kex2p, but is absent in 
bacterial subtilisins. A transmembrane domain is also seen in some SPC’s (Furin, 
PC5 and PC7). Towards the C-terminus, furin, PACE4 and PC5/PC6 A and B
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have a Cys-rich domain o f unknown function. Overall, PACE4 and PC4 are very 
similar to furin, while PC I, PC2 and PC7 are increasingly different from furin (7, 
13). Figure 1 shows the structural organization o f most SPC’s.
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Figure 1: Schematic representation of SPC’s. For each region, the percentage 
of amino acid identity with furin is shown. Also, the catalytic residues (Asp, His, 
Ser, and Asn or Asp) and the Arg-Gly-Asp (Ser) (Recognition sequence for 
integrins) sequences are shown (7). The more distantly related members o f the 
family (SKI-1 and PCSK9) are not included.
Activation and Localization
SPC’s are initially synthesized as zymogens. An initial autocatalytic 
processing event in the endoplasmic reticulum (ER) (all SPCs except for PC2) or 
in immature secretory granules (PC2) generates a heterodimer of the inhibitory 
prosegment and the rest o f the molecule (prosegment-SPC). The heterodimer exits
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the ER and sorts to specific subcellular compartments, where the full catalytic 
activity is acquired, usually following a second autocatalytic cleavage of the 
prosegment. This liberates the active enzyme from the inhibitory prosegment. 
This exquisitely well-orchestrated zymogen activation mechanism ensures that the 
convertase is only active at intracellular site(s) where the conditions of pH and 
calcium are optimal for the in trans cleavage of specific substrates. Only the 
mature enzyme is assumed to be capable of processing substrates; therefore, 
removal of the pro-domain seems to be essential for acquiring substrate cleavage 
activity (14).
Furin, PCS and PC7 have transmembrane domains and are localized in the 
trans-Golgi network (TGN). Furin is a trans membrane protein with a type I 
topology. Furin is initially synthesized as a pro-furin zymogen, which is rapidly 
converted into active furin by intermolecular, auto-cleavage of the propeptide at 
the Arg-Ala-Lys-Arg site (residuesl04-107). The autocatalytic cleavage of the 
propeptide appears to occur in the endoplasmic reticulum (ER). Propeptide 
cleavage is a prerequisite for transport of furin molecules out of the ER, but 
propeptide cleavage is not sufficient for the activation of furin. Even after its 
cleavage in the ER, the propeptide remains associated with the furin active site 
and functions as a potent autoinhibitor of the endoprotease. The propeptide 
release requires a second cleavage at the Arg-Gly-Val-Thr-Lys-Arg site (residues 
70-75) in the middle of the propeptide. This cleavage is dependent upon the acidic 
pH in the Golgi apparatus. Furin ultimately cycles between the TGN and the cell
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surface. Furin shows its protease activity in a broad pH range of 6.0 to 8.5, with a 
peak at 7.0 (7). However, the kinetics of the initial proprptide cleavage in the ER 
(pH 7.0) and the second cleavage in the Golgi apparatus (pH 6.0) suggest that 
furin can have different activity at different pHs. This could have implications for 
the substrate specificity o f TGN-associated versus secreted forms of furin.
ProPACE4 (approximately 106 KDa) is cleaved intracellularly before the 
secretion of PACE4 (approximately 97 K Da). PACE4 seems to be activated in 
the TGN and/or at the cell surface (15). The neuroendocrine-specific convertases, 
PC2 and PC1/PC3, are mainly localized in secretory granules. PC5/PC6A has also 
been reported to be localized to secretory granules (7). Pro-PC7 is synthesized as 
glycosylated zymogen (101 KDa) and processed into mature PC7 (89KDa) in 
endoplasmic reticulum (16). SKI-1 is active in the cis/medial-Golgi. Furin, 
PACE4, PC5 and PC7 are widely expressed and function in the secretory pathway 
of many different mammalian cell types (4, 7, 9, and 10). These four widely 
expressed members o f the SPC family are the focus o f this project.
Importance of SPCs
SPC’s have important roles in development and homeostasis. They cleave 
and activate peptide hormones, neuropeptides, growth factors, receptors, adhesion 
molecules, plasma proteases, matrix degrading metalloproteinases, and other 
enzymes. Their importance is illustrated by knockouts in mouse models, which 
are either embryonic lethal or result in severe developmental abnormalities (17).
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SPCs also activate proteins involved in infectious disease. These include 
bacterial toxins, such as Pseudomonas exotoxin A, diphtheria toxin, anthrax toxin, 
aerolysin, botulinum neurotoxin and tetanus neurotoxin. SPC’s activate viral 
glycoproteins, notably gpl60 of the Human Immunodeficiency Virus (HIV), the 
fusion protein o f measles virus, and the envelope glycoprotein of Ebola virus. 
SPC’s are also capable o f activating respiratory viruses such as human influenza 
virus and Sendai virus (17).
SPCs also play a role in non-infectious pathological conditions. For 
example, they activate the Alzheimer’s disease p-secretase, which is one of the 
enzymes involved in cleaving the amyloid precursor protein (18-20). Aberrant 
cleavage by SPC’s causes three rare autosomal dominant neurodegenerative 
diseases, namely familial amyloidosis o f Finnish type, familial British dementia, 
and familial Danish dementia (17). Furin activates the insulin proreceptor and 
pro-clotting factor IX; lack of furin activity versus these proproteins can result in 
insulin-resistant diabetes and hemophilia B (21-23).
SPCs are also over-expressed in some cancers, and expression level 
appears to correlate with malignancy (24-25). SPC activity may contribute to 
tumor development through activation of paracrine factors and receptors involved 
in controlling cell differentiation and proliferation (26). SPCs may facilitate 
metastasis through activation of matrix-degrading metalloproteinases (24). Furin
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and PACE4 process stromelysin 3, an MMP involved in tumor invasion. 
Similarly, MT-MMPs (Membrane-type Matrix degrading Metalloproteinase) and 
adhesion molecules, such as E-cadherin, may be activated by furin and PACE4 
(24). PC7 is expressed abundantly in activatable immune cells such as CD4+ T- 
lymphocytes, suggesting PC7 may play an important role in processing of tumor 
necrosis factor and integrins (16). Activation of transforming growth factor-beta 
by furin and other SPCs may contribute to the immunosuppression seen in many 
types o f cancer (27).
Despite the high degree of homology in the PC family, only PACE4 and 
furin localize to the same chromosome: mouse chromosome 7 and human 
chromosome 15. Furin knockouts are embryonic lethal in mouse models (28), and 
cell strains harboring loss-of-function mutation in fu r  alleles are deficient in the 
activation of variety of proproteins (26, 28, 30-32). PACE4 plays a critical role in 
axis formation during mouse development (27). Thus, widely expressed SPCs 
have enormous biomedical importance, with key roles in development, 
homeostasis and pathology.
Substrate Binding and Specificity
SPCs are similar at the level of primary structure and have many common 
biochemical characteristics. However, these enzymes differ in their substrate 
specificity. Examination of amino acid sequences around the cleavage site of 
many mammalian precursor polypeptides shows a common motif, typically N-
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Arg-X-X-Arg-C. The substrate binding region of all SPC’s contains subsites 
(designated as S1-S4) with negatively charged residues, which may interact with 
the positively charged residues of substrates. The affinity of the substrates to the 
endoproteases may be determined by the number o f interactions between the 
negative charges of the subsites and the positive charges of the substrates.
P6 PS P4 P3 P2 PI PT P2'• I I f f  I mm I *4* I ■ mm
X X Arg X X Arg X X
Figure 2: The canonical SPC cleavage site and nomenclature of amino acids 
in the cleavage site. PI is the carboxy most Arginine, P2 is the residue amino 
terminal to P I, P l ’and P2’ are the residues carboxy terminal to PI. Arg indicates
Arginine and -J- is the peptide bond that is hydrolyzed.
It was demonstrated that negatively charged residues in or near the S1-S4 
subsites o f the substrate binding region are critical in furin (12). The SI binding 
pocket is predicted to be a large, elongated pocket involved in electrostatic 
interaction with the PI basic residue (29). However, according to the number and 
distribution of these negative charges the PCs differ slightly from each other. 
Furin, with 16 acidic residues (including Asp 153, Asp228, Glu299, Glu301, 
Glu331 and Asp522) in the immediate vicinity of the active-site cleft, possesses 
the highest number of negative charges. PACE4, PC5 and PC4, with 15 acidic
residues each, exhibit a similar negative charge density, while PC7, PCI and PC2
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contain 13 acidic residues (12). Therefore, the overall requirement for positively 
charged residues N-terminal o f the cleavage site o f bound substrates might be 
expected to decrease in the same order (33).
The requirement of Arg at position PI is a common feature of the SPCs. 
The published sequence rules (29-34) that govern the constitutive precursor 
cleavage are:
1. A basic residue at the P4 or P6 position upstream of the cleavage 
site is usually required.
2. At position P2, a basic residue may be required, with Lys more 
favorable than Arg.
3. At position P4, Arg is more favorable than Lys.
4. At position PI a hydrophobic aliphatic residue is not suitable.
Substrate specificities of furin and PACE4 have been most thoroughly 
investigated, with less known about PC5 and PC7. PACE4 is unable to process 
several proproteins acted upon by furin. The restricted substrate range of PACE4 
may reflect a unique physiological role for PACE4. Some proteins activated by 
furin but not by PACE4 are involved in disease development, including 
Pseudomonas exotoxin A (35), avian influenza hemagglutinin (36), and 
Newcastle disease virus F protein (37). gp 160 of the human immunodeficiency 
virus type I can be processed by furin, but is less efficiently processed by PACE4 
(38-40). Furin can effectively recognize the cleavage sequence N-Arg-X-X-Arg-C
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(41-42). The PACE4 cleavage sequence appears to be more restrictive. PACE4 
may require a basic residue—Lysine or Arginine—in the P2 position and optimal 
cleavage sequence for PACE4 has been described as N-Arg-X-Lys/Arg-Arg-C 
(11, 43). Interestingly, PACE4 is unable to process several proteins containing 
the N-Arginine-X-Lysine/Arginine-Arginine-C cleavage sequence, suggesting 
others factors influence substrate selectivity of PACE4. Other experimentation on 
the sequence m otif necessary for cleavage by PACE4 is ambiguous. Some reports 
suggest that PACE4 can recognize the Arg-X-X-Arg sequence and sequences that 
lack a P4 arginine residue. Thus, the precise role of the P2 residue in the substrate 
specificity of PACE4 is not clear. While less is known about substrate specificity 
o f PC5 and PC7, each member o f SPCs appears to have different substrate 
specificity. This could impart a specific physiological role to each enzyme, as 
well as influence their ability to activate proteins involved in the development of 
disease conditions (44-46).
Enzyme Substrate Interaction
Molecular modeling studies have suggested that all residues which are 
closely associated with the substrate binding cleft o f SPCs interact with amino 
acids in cleavage site o f substrate. Amino acids in the SI subsites are conserved 
among SPC’s (Table 1). Amino acids in the S4 subsites are also conserved expect 
for PC1/PC3. However, the amino acids at the 90 and 94 positions (residue 
number corresponding to PACE4) in the S2 subsite are different for furin and 
PACE4. These residues may therefore play an important role in substrate 
preference of these SPC’s by mediating interaction with the P2 residue in
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substrate proproteins (13). Specifically, the presence of an acidic residue at 
position 90 in PACE4 and the longer side chain of Glu 94 (PACE4) compared to 
Asp (furin) could be important in mediating interactions with basic P2 residues. 
These differences might account for the cleavage site selectivity of furin and 
PACE4.
S4 S3 S2 SI
E D D D D E N D D
140 168 161 63 90 94 95 210 162
Furin E D E D T D N D D
PACE4 E D D D D E N D D
PC5/6 E D D D D E N D D
PC4 E D E D T E N D D
PCI/3 E E N D D E N D D
PC7 E D D D D G N D D
PC2 E D T D T F N D D
Kexin E Q A D D D D D
Table 1: Amino acids in SPC subsites that may interact with
substrateresidues. Residue numbering is for PACE4. Single letter amino acid 
abbreviations are used. The S2 subsite is highlighted and potentially important 
differences at positions 90 and 94 are indicated.
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Our Study
We examined if the sequence variation at P2 residues determines the 
ability o f SPCs to recognize, bind and act upon a proprotein. Amino acids within 
the catalytic domain of the SPCs that may play a role in substrate preferences, 
particularly Asp90 and Glu94 which may interact with P2 side chains, are also 
examined for PACE4. According to molecular modeling studies, comparison of 
negatively charged and presumably critical amino acid residues in the S2 subsites 
of human furin and human PACE4 revealed differences (Table 1). These could 
constitute an important factor for observed difference in cleavage site selectivity 
between furin and PACE4 (12). To understand where the actual interaction of 
amino acids takes place between PACE4 and substrates, we created three mutants 
o f PACE4, called E94D, D90T and double mutant (a combination of both E94D 
and D90T). These changes might make the S2 site o f PACE4 mimic that of furin, 
with a corresponding change in the substrate specificity. Finally, to examine the 
substrate preferences of furin in TGN and secreted furin, substrate specificity of 
furin was examined at pH 6 and pH 7.
Substrate specificity was analyzed both qualitatively and quantitatively. 
For qualitative analyses we used von Willebrand’s factor (vWF) as a model 
substrate and examined the ability o f widely expressed SPCs to act upon wild 
type or mutant versions differing in the P2 residue, von Willebrand’s factor is 
synthesized as a 2,813 residue proprotein and is a good substrate o f SPCs. 
Maturation of pro-von Willebrand factor to its active form requires proteolytic
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processing. Correct processing of vWF is essential for its ability to bind and 
stabilize factor VIII during clotting. Quantitative analysis was done using 
synthetic peptides as substrates, which are linked to a fluorescent dye. We used 7 
peptides, with wild type substrate having Arginine at the P2 position and the 
others having substitution of polar, non polar, or acidic amino acids.
Furin, PACE4, PC5 and PC7 are the major group of enzymes involved in 
processing many proproteins that traverse the secretory pathway and are involved 
in number of infectious and non-infectious diseases. Designing an inhibitor for 
one or more SPC’s could be very beneficial in treatment o f several pathologies. 
Therefore, knowledge about substrate specificity o f each enzyme is critical. 
Hence, the result of our research could be used as preliminary data for drug 
designing.
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Materials and Methods
Cell Culture
Cells used in this study were RPE.40 cells, which are a strain of SPC- 
deficient Chinese hamster ovary cells. Cells were cultured in Dulbecco’s modified 
Eagle’s medium/Ham’s F-12 (Gibco-BRL; Gaithersburg, MD) containing 5% 
fetal bovine serum (Gibco-BRL) at 37° C in a 4.7% CO2 atmosphere.
Construction of Mutant PACE4 Expression Vector for Stable 
Expression
Three mutants of human PACE4 cDNA were previously created, namely 
D90T, E94D and Double Mutant (DM), which is a combination of both D90T and 
E94D. All three mutants were cloned in the pSVL expression vector 
(Pharmacia/GE Healthcare; Piscataway, NJ), which does not contain a selectable 
marker. To generate cells stably expressing these mutants, the PACE4 cDNAs 
were excised from pSVL using a BamHI/XhoI double digest. The mutant PACE4 
cDNAs were then purified from agarose by using the Wizard PCR preps DNA 
purification system (Promega; Madison, WI), in accordance with the 
manufacturer’s instructions. The cDNAs were then directionally ligated into the 
expression vector pcDNA 3.1 (-) (Invitrogen; Carlsbad, CA), which harbors a 
gene conferring resistance to geneticin (G418), by using the same restriction sites 
(BamHI/Xhol). Ligation products were transformed into Escherichia coli XL1- 
Blue cells (Stratagene; La Jolla, CA) and transformants harboring the constructs 
were selected by growth on Ampicillin-containing (200mg/ml) Luria-Bertani
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medium. The presence of the constructs was verified by standard plasmid prep 
(QIAGEN; Valencia, CA) and restriction digestion analysis. Large scale isolation 
o f the recombinant constructs, designated pcDNA 3.1-E94D, pcDNA3.1-D90T 
and pcDNA3.1-DM, was done by using a plasmid isolation kit obtained from 
Marligen (Ijamsville, MD) according to manufacturer’s instructions.
Stable Transfection
The generation of cells stably expressing human PACE4 mutants (E94D, 
D90T and DM) was done by transfecting pcDNA3.1-mutant PACE4 constructs 
into RPE.40 cells. For all transfections, 105 cells were seeded in 3 ml of growth 
medium in 60mm><15mm (P60) tissue culture dishes and incubated for 12h before 
transfection was initiated. Transfections were done with Transit transfection 
reagent from Mirus (Madison, WI) in accordance with manufacturer’s 
instructions. After 24h cells were supplemented with new serum-free medium 
(HyQ-CCM, from HyClone Laboratories; Logan, UT). After 48h G418 was added 
(850pg/mL). After 60 hours cells were washed with IX Phosphate Buffered 
Saline (PBS) and supplemented with new medium containing G418 (850pg/ml). 
Two days later cells were transferred to four 60mm><15mm tissue culture dishes 
and supplemented with growth medium containing G418 (850pg/mL). After 60 
hours, 3 colonies were selected for each mutant and transferred into three, 
35mmx 10mm tissue culture dishes (P35s). After 60h the cells were transferred to 
25 centimeter square flask (T25). Freezer stocks o f these cells were made for 
future use.
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Synthesis and Ultra-purification of SPCs
RPE.40 cells harboring constructs for furin, wild type PACE4, PC5 and 
PC7 were previously generated. RPE.40 cells harboring these constructs, as well 
as the E94D, D90T, and DM plasmids, were grown in 150 cm2 flasks (T150) 
using growth medium supplemented with 850pg/mL G418. After 12 h cells were 
washed two times with Phosphate-Buffered Saline (PBS) containing magnesium 
and calcium ions. Then cells were supplemented with serum-free OPTI-MEM + 
GlutaMAX (Gibco-BRL) with 850pg/mL G418.
After 72 h medium was harvested and centrifuged for 5 min at 2900 RCF 
to separate the cells from the medium. The enzymes in the conditioned medium 
were obtained by passing the medium through Centriplus YM-50 ultrafiltration 
tubes (Millipore; Bedford, MA) at 2900 RCF for 45 min. The enzymes were then 
stored at -20°C for future analysis.
Production of Pro-von Willebrand’s Factor (Pro-vWF)
Escherichia coli XL1- Blue cells harboring constructs for wild type and 
mutant pro-vWF were previously created. Wild type pro-vWF has Lys at position 
762 (K762, which is the P2 position), and mutant pro-vWF has different amino 
acid substitutions to the P2 residue, including K762S, K762G, K762D, K762A, 
K762V, and K762L. These cells were grown in Ampicillin-containing (200 
pg/mL) Luria-Bertani medium. Purification of recombinant constructs was done 
by using a plasmid isolation kit from QIAGEN (Valencia, CA). These constructs
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were transiently introduced into RPE.40 cell using Lipofectamine reagent (Gibco- 
BRL) in accordance with the manufacturer’s protocol; for these transient 
transfections, 5X105 RPE.40 cells were seeded in 3mL of growth medium in P60 
tissue culture dishes and incubated for 12 h before transfections were initiated. 
After transfections, cells were incubated in growth medium for 5 hours and then 
switched to serum-free medium (HyQ-CCM), After 60 h, medium containing 
secreted vWF was harvested and centrifuged for 5 min at 13,000xg. The 
conditioned medium containing vWF was stored at -20°C for future analysis.
Generation and Production of Pro-von Willebrand’s Factor 
Mutant K762N
The construct encoding the precursor to von Willebrand’s factor (pro- 
vWF) was provided by Dr. Jan A. van Mourik and Dr. Jan Voorberg of the central 
laboratory of the Netherland Red Cross Blood Transfection Service (Amsterdam, 
The Netherlands). Site-directed mutagenesis was done to create the K762N 
mutant of pro-vWF using the QuikChange XL kit (Stratagene) according to 
manufacturer’s instruction. The primers used to create K762N were
Top: 5’-CCCCTGTCTCATCGCAGCAACAGGAGCCTATCCTGTCGG-3 ’
Bottom: 5’-CCGACAGGATAGGCTCCTGTTGCTGCGATGAGACAGGGG-3’
The product o f site-directed mutagenesis was sequenced by University of 
Michigan Sequencing Core Facility (Ann Arbor, MI) to confirm the mutation. 
The plasmid containing K762N pro-vWF was transformed into Escherichia coli
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XLl-Blue cells and transformants harboring the construct were selected by 
growth on Ampicillin-containing Luria-Bertani medium (200|ug/ml). Freezer 
stocks were made for future use.
The plasmid harboring K762N was transiently introduced into RPE.40 
cells as described previously for other mutant forms of vWF. After transfections, 
cells were incubated in growth medium for 5 hours and then switched to serum- 
free medium OPTI-MEM + GlutaMAX (Gibco-BRL). After 60 h, medium 
containing secreted vWF was harvested and centrifuged for 5 min at 13,000xg. 
The conditioned medium containing vWF was stored at -20 for future analysis.
Quantitative Analysis: Fluorimetric Reactions
The peptides for fluorimetric analysis contain four amino acids linked to a 
fluorescent dye called 7-Amino-4-Methylcoumarin. They were obtained as 
granules from Peptides International (Louisville, KY). Each was re-suspended in 
100% DMSO at a concentration of 10 mM, according to the manufacturer’s 
instructions. For reactions, 5 mM working solutions of the peptides were used, 
which were diluted from the stock solution using IX IVP {In Vitro Processing 
Buffer; 0.1 M HEPES and 3 mM CaCk). For Km determination, increasing 
amounts o f substrates were added to the reaction mixture. The setup for 
Fluorimetric reactions to analyze substrate specificity was done as described in 
the table 2.
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Tube# Enzyme
0*L)
Substrate
(pL)
5 mM
10X IVP 
Buffer 
(pL)
Water
(PL)
Fluorescent 
Intensity 
Unit (FIU)
FIU
l 0 1 20 179 Background
fluorescence
Actual
Fluorescence
2 5 l 20 174
3 0 2 20 178
4 5 2 20 173
5 0 4 20 176
6 5 4 20 171
7 0 8 20 172
8 5 8 20 167
9 0 10 20 170
10 5 10 20 165
11 0 20 20 160
12 5 20 20 155
13 0 40 20 150
14 5 40 20 145
15 0 50 20 140
16 5 50 20 135
ble 2: 1t emplate for fluorimetric reactions. Indicated volumes of eac
reagent were added to each reaction; note that even numbered reactions were 
controls lacking any processing enzyme. Reactions were incubated for 37°C for 
30 min.
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The reaction tubes were incubated at 37 C for 30 min in a PCR machine and then 
analyzed for fluorescence.
The flourimeter (Quantech Model Number FM109515, Bamstead 
International; Dubuque, IA) was standardized using 7-amino-4-methylcoumarin 
(AMC), with 0.1 mM set to generate 1000 Fluorescent Intensity Units (FIU) 
according to manufacturer’s instruction. The background fluorescence was 
subtracted from the reaction fluorescence to obtain FIU corresponding to 
fluorescent dye released during the reaction.
Michaelis-Menten Constant (Km) Calculation
/
max
Figure 3: Calculation of Km from a graph plotting substrate concentration 
versus reaction rate (49).
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Km is a constant that describes the relative affinity of enzymes for 
particular substrates. Km is equal to the substrate concentration at which an 
enzyme reaction proceeds at half the maximum velocity (Figure 1). Therefore, the 
lower the Km the higher the affinity of enzyme for substrate.
The Km for all reactions was calculated in pM, using a software program 
called GraphPad Prism (GraphPad Software, Inc; La Jolla, CA). Both graphs (like 
shown in Figure 1) and values for Km were generated.
Quantitative Method: Western Blotting
Activity o f SPCs was tested using wild type and mutant pro-vWF as substrate.
The SPC’s used in these reactions are not purified enzymes, so a volume of each 
enzyme processing approximately 90% of wild type pro-vWF to its mature form 
was standardized (Table 3).
SPC’s Volume
(HL)
Furin 3
PACE4 2
E94D 1
D90T 16
DM 8.5
PC5 16
PC7 16
Table 3: Volumes used for each SPC during quantitative processing 
reactions.
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The amount of vWF used in every reaction was standardized by using wild type 
vWF as control, and is shown in table 4.
vWF Volume (pL)
Wild type 20
K762S 15
K762G 15
K762D 15
K762A 10
K762L 20
K762V 20
Table 4: Volumes used for wild type and mutant forms of pro-vWF during 
quantitative processing reactions.
For every pro-vWF processing reaction, 4pL of 10X IVP 
buffer at pH 7.0 was used except for the reactions to check the substrate 
specificity of furin at pH6, where 4pL of 10X IVP buffer at pH 6.0 was used. 
Total volume for every reaction was maintained at 4 0 jliL  by using sterile water. 
Reaction tubes were incubated at 37°C for 16 h. Western blotting was done as 
described by Sucic et.al, (35).
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Results
Quantitative Results
Furin Furin PACE4 E94D D90T DM PC5 PC7
R-T-K-R 21.87 17.02 8.86 39.44 161.33 34.91 12.43 74.20
± ± ± ± i ± ± ±
2.80 2.17 1.10 6.75 12.96 14.04 2.77 13.87
R-T-S-R 39.75 39.50 96.60 141.40 27.46 82.91 84.57 185.10
± ± ± =t ± ± ±
8.32 4.22 12.90 24.68 9.20 11.10 6.14 28.55
R-T-N-R 29.01 34.23 82.51 75.94 76.87 80.78 55.13 136.10
± ± ± ± it ± ± ±
4.85 4.04 14.53 15.10 11.59 15.24 6.41 23.42
R-T-G-R 94.14 Not 157.80 173.53 Not 137.86 97.10 206.18
± Determined ± ± Determined ± ±
6.65 22.75 23.35 44.16 23.77 42.3
R-T-D-R 181.78 87.68 205.20 340.63 40.73 Not 119.67 156.00
± ± ± ± ±
Determined ± ±
29.55 6 30.08 48.71 7.79 27.62 2.94
R-T-A-R 120.00 55.85 215.53 217.17 68.59 252.13 142.80 224.33
± ± ± ± ± ± i
16.24 7.16 28.26 28.30 15.1 39.18 4.69 28.44
Table 5: Quantitative in vitro processing results. Each SPC was incubated with 
fluorogenic substrates for 30 minutes, following the reaction protocol shown in 
Table 2. Fluorescence liberated by SPC cleavage was then quantified by 
fluorimetry and was used to generate Km values, which are shown along with 
standard error. Km values are in pM. In a few cases, values were not determined 
because o f limited substrate availability.
24
For quantitative analysis of substrate specificity, each wild type or mutant 
enzyme was used with a synthetic peptide conjugated to a fluorescent dye. The 
peptides differed in the amino acid at the P2 position. Recognition and cleavage 
of the peptide by the enzyme resulted in liberation of the fluorescent dye, which 
was quantified and used to generate a Km. Results are shown in Table 2; each 
Km represents the mean of at least three separate experiments.
Results show that each enzyme has unique substrate preferences. Furin (at 
pH 7.0) showed the highest affinity for the wild type substrate (R-T-K-R; Km of 
21.87) with a basic P2 residue. Furin also showed relatively high affinity for 
substrates with polar residues in the P2 position (R-T-N-R, with a Km of 29.01, 
and R-T-S-R, with a Km of 39.75). Substrates with non-polar P2 residues were 
processed much less efficiently (R-T-G-R, with a Km of 94.14, and R-T-A-R, 
with a Km of 120.00). Furin showed the least affinity for R-T-D-R (Km of
181.78), which has an acidic P2 residue. At pH 6.0, furin exhibited the same 
preference of substrates, although the Kms for each substrate were generally 
lower that at pH 7.0 (see Table 1). This suggests that furin may work more 
efficiently within the Golgi apparatus than in other environments.
PACE4 (at pH 7.0) showed the highest affinity for the wild type substrate 
(R-T-K-R; Km of 8.86) with a basic P2 residue. PACE4 also showed relatively 
high affinity for substrates with polar residues in the P2 position (R-T-N-R, with a
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Km of 82.51, and R-T-S-R, with a Km of 96.60). Substrates with non-polar P2 
residues were processed much less efficiently (R-T-G-R, with a Km of 157.80, 
and R-T-A-R, with a Km of 215.53). PACE4 showed low affinity for R-T-D-R 
(Km of 181.78), which has an acidic P2 residue. Overall, PACE4 had generally 
higher Kms compared to furin, suggesting that PACE4 acts with less efficiency.
E94D (at pH 7.0) showed the highest affinity for the wild type substrate 
(R-T-K-R; Km of 39.44). E94D also showed relatively high affinity for substrates 
with polar residues in the P2 position (R-T-N-R, with a Km of 75.94, and R-T-S- 
R, with a Km of 141.40). Substrates with non-polar P2 residues were processed 
less efficiently (R-T-G-R, with a Km of 173.53, and R-T-A-R, with a Km of 
217.17). E94D showed the low affinity for R-T-D-R (Km of 181.78), which has 
an acidic P2 residue.
Overall substrate preferences of D90T were markedly different, 
suggesting a key role for Asp 90 in mediating interaction with P2 residue. D90T 
showed highest affinity for a substrate with a polar residue in the P2 position (R- 
T-S-R, with a Km of 27.46). D90T showed relatively high affinity for the R-T-D- 
R (Km of 40.73) with an acidic P2 residue. A substrate with a non-polar P2 
residue was processed less efficiently (R-T-A-R, with a Km of 68.59). The 
affinity of D90T for R-T-N-R (Km of 76.87) was low. Interestingly, D90T 
showed the least affinity for wild type substrate (R-T-K-R, with a Km of 161.33), 
which has a basic P2 residue.
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DM showed the highest affinity for the wild type substrate (R-T-K-R; Km 
of 34.91). DM also showed relatively high affinity for substrates with polar 
residues in the P2 position (R-T-N-R, with a Km of 80.78, and R-T-S-R, with a 
Km of 82.91). Substrates with non-polar P2 residues were processed much less 
efficiently (R-T-G-R, with a Km of 137.86, and R-T-A-R, with a Km of 181.78. 
DM substrate preferences largely did reflect those of furin, but with higher Km.
PC5 showed the highest affinity for the wild type substrate (R-T-K-R; Km 
of 12.43) with a basic P2 residue. PCS also showed relatively high affinity for 
substrates with polar residues in the P2 position (R-T-N-R, with a Km of 55.13, 
and R-T-S-R, with a Km of 84.57). Substrates with non-polar P2 residues were 
processed much less efficiently (R-T-G-R, with a Km of 97.10, and R-T-A-R, 
with a Km of 142.80). PC5 showed the least affinity for R-T-D-R (Km of
181.78).
PC7 showed the highest affinity for the wild type substrate (R-T-K-R; Km 
of 74.20). PC7 also showed relatively high affinity for substrates with polar 
residues in the P2 position (R-T-N-R, with a Km of 136.10, and R-T-S-R, with a 
Km of 185.10). PC7 showed the low affinity for R-T-D-R (Km of 156.00). 
Substrates with non-polar P2 residues were processed much less efficiently (R-T- 
G-R, with a Km of 206.18, and R-T-A-R, with a Km of 224.33). Overall, PC7 
appeared to be the least efficient enzyme, with relatively high Kms for each 
substrate.
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Qualitative Results
For qualitative analysis of substrate specificity, each wild type or mutant 
enzyme was used with wild type and mutant von Willebrand’s factor. The mutant 
von Willebrand’s factor differed in the amino acid at the P2 position (K762 in 
wild type von willebrand’s factor).
Furin Furin
Control pH 7.0 pH 6.0 PACE4 E94D D90T DM PC5 PC7
P ro wt vWF
Mature wt vWF
Pro K762S  
Mature K762S
Pro K762G 
Mature K762G 
Pro K762A 
Mature K762A 
Pro K762V
Mature K762V  
Pro K762L 
Mature K762L 
Pro K762D
Mature K762D
Figure 4: Processing ability of SPCs against wild type and mutant vWF. Each 
enzyme was incubated with each protein at 37°C for 16hrs. Proteins in the 
reaction were resolved using SDS-PAGE, and von Willebrand’s factor was 
detected using western blotting. Processing of pro-von Willebrand’s factor causes 
a significant molecular weight decrease, as indicated.
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Furin (at pH 7.0) processed wild type vWF (with a basic P2 residue) 
approximately 90%. Furin also processed K762G and K762A efficiently (with 
non-polar residues in the P2 position), but processing of K762V and K762L (also 
non-polar P2 residues) was minimal (approximately 2%). K762S, with a polar P2 
residue, was processed at the same efficiency as K762A (approximately 20%). 
Furin did not process K762D, which has an acidic P2 residue. At pH 6.0, furin 
exhibited the same preference of substrates.
PACE4 processed wild type vWF efficiently. PACE4 also processed 
K762G and K762A (approximately 40% and 60%), but very little processing was 
seen for K762V and K762L (approximately 10% and 1%); all of these have non­
polar residues. K762S, with a polar P2 residue, was processed at the same 
efficiency as K762G (approximately 40%). Processing of K762D, which has an 
acidic P2 residue, was minimal.
E94D processed wild type vWF very efficiently. Among substrates with 
non-polar residues, E94D processed K762G and K762A (approximately 75% and 
30%), but very little processing was seen for K762V and K762L (approximately 
10% and 1%). K762S, with a polar P2 residue, was processed somewhat more 
efficiently than K762G (approximately 40%), but less efficiently than K762A. 
Processing of K762D, which has an acidic P2 residue, was minimal.
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D90T processed approximately 50% of wild type vWF. D90T also 
processed K762G and K762A (non-polar residues in the P2 position) at the same 
efficiency as wild type vWF, but very little processing was seen for K762V and 
K762L (approximately 10% and 1%), which also have a non-polar amino acid at 
P2 position. K762S was processed less efficiently than substrates with non-polar 
amino acid at P2 position (approximately 35%). Processing of K762D was 
minimal (approximately 5%). Thus, D90T also exhibits markedly different 
preferences for mutants o f pro-vWF compared to the other enzymes.
DM efficiently processed wild type vWF. DM also processed K762G and 
K762A, but less efficiently than the wild type (approximately 60% and 50%); but 
very little processing was seen for K762V and K762L (approximately 20% and 
1%). K762S (polar P2 residue) was processed less efficiently than K762G and 
K762A (approximately 40%). Processing of K762D, which has an acidic P2 
residue, was minimal.
PC5 processed wild type efficiently. PC5 also processed K762G and 
K762A, with non-polar residues in the P2 position, but less efficiently than wild 
type (approximately 60%); very little processing was seen for K762V and K762L 
(approximately 20% and 25%), which also have non-polar amino acid at P2 
position. K762S (polar P2 residue) was processed less efficiently than substrates 
with non-polar amino acids at P2 position (approximately 50%). Processing of
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K762D, which has an acidic P2 residue, was minimal, but did occur more 
efficiently than for either furin or PACE4.
PC7 processed wild type vWF very efficiently. PC7 also processed 
K762G and K762A (approximately 80%), but less processing was seen for 
K762V and K762L (approximately 30% and 25%). K762S was processed less 
efficiently than substrates with non-polar amino acids at the P2 position 
(approximately 65%). Processing of K762D was less efficient, but more 
pronounced than for furin or PACE4.
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Discussion
Widely expressed SPCs play critical roles in development, homeostasis, 
and pathology; however, specific roles for each enzyme remain elusive, in part 
because of some redundancy in substrate preferences. While some redundancy 
does exist, many reports also suggest that each enzyme has unique substrate 
preferences, which could underlie unique physiological and pathological roles. In 
particular, furin and PACE4 have been reported to vary in their requirements for a 
P2 residue, with PACE4 having more stringent requirements; indeed, some 
reports have suggested that PACE4 requires a basic P2 residue, although other 
experimentation does not support this (12 and 43). We set out to systematically 
examine the P2 requirements of all four widely expressed SPCs, using a 
combination of quantitative and qualitative methods.
Overall quantitative results suggest that P2 substrate specificities of the 
widely expressed SPCs are similar, with basic and polar amino acids being 
generally preferred over non-polar and acidic residues at the P2 position. 
However, each enzyme does appear to have unique preferences. Furin, 
particularly at pH 6.0, appears to be the broadest and most efficient enzyme. 
Others have shown that furin can have different substrate specificities at pH 6.0 
versus 7.0. The most well-documented example occurs during furin maturation, 
where the inhibitory propeptide is auto-cleaved in the Golgi apparatus at the 
sequence N-Arg-Ala-Val-Thr-Lys-Arg-C (47 and 48). Furin has a much lower 
Km for this sequence at pH 6.0 than pH 7.0, ensuring that activation does not
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occur until transit to the Golgi. Since furin primarily localizes to the Golgi, the 
increased efficiency of furin at pH 6.0 suggest that furin is extremely proficient at 
processing proteins that traverse through the Golgi.
PACE4 efficiency versus peptides is not in complete agreement with some 
published results done with protein substrates (12 and 43). For example; our 
results show PACE4 has a higher affinity for peptide substrates with an acidic P2 
residue compared to a hydrophobic residue; published results done on protein 
substrates showed the opposite preference. Overall, quantitative results show that 
PACE4 has stringent P2 requirements. The stringent specificity may be because 
of aspartic acid at position 90 (D90) and glutamate at position 94 (E94) in the S2 
subsite. In contrast, furin has threonine at position 90 and aspartic acid at position 
94, which might give furin more tolerance for substrates that lack a basic 
(positively charged) P2 residue. PC7 appears to be the least efficient, perhaps 
consistent with its proposed role as a completely redundant member of the family; 
its relatively high Kms toward substrates with basic, polar, and non-polar P2 
residues could be the result of a glycine substitution for E94, which removes a 
negative charge from the S2 subsite and replaces it with a non-polar aminoacid.
Overall qualitative results were not always in agreement with results 
obtained with the peptides, but generally support the conclusions that P2 
preferences are generally similar among the widely-expressed SPCs, although 
each enzyme may have some unique properties. Furin and PACE4 results are
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somewhat inconclusive and in conflict with published reports (need future 
experimentation). PC7 appears broader against the protein substrates. It processed 
mutant proteins with aspartic acid at the P2 position more efficiently than furin 
and PACE4. This may be because of effects o f the amino acid substitutions on 
overall conformation of the von Willebrand’s factor. Such structural changes may 
result in impaired interaction with enzymes that are not directly due to 
interactions between the P2 residue and the S2 subsite.
We also attempted to investigate the molecular basis for the restricted 
range of PACE4 regarding P2 preferences. Toward this end, we used site- 
directed mutagenesis to change two amino acids that may be important at the S2 
subsite (D90 and E94) to the residues seen at those positions in furin (threonine 
and aspartic acid, respectively)(Figure 2). We hypothesized that these changes, 
individually or together, might result in an enzyme with the P2 preferences of 
furin. Results do suggest an important role for D90. The D90T mutant had 
markedly different substrate preferences than all other mutants. D90T was much 
more tolerant o f acidic and hydrophobic P2 residues and also it showed low 
affinity towards a basic P2 residue. This suggests that in PACE4, D90 (negatively 
charged) may interact with positively charged P2 residues. When D90 is changed 
to a threonine (lacking the negative charge of D90) the S2 subsite may be much 
more accommodating of side chains with negative charges or hyprohobic 
properties. Except for K762D, these results were largely also seen with a protein 
substrate.
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Results suggest that E94, alone, plays a limited role, if any, in mediating 
P2 preferences in PACE4. In the double mutant, substrate preferences did mimic 
those o f furin, but with overall higher Kms. Substitution of two different amino 
acids at 90 and 94 the position may cause structural changes in the S2 subsite of 
DM. The structural changes may be the reason for higher Kms of DM, though the 
range of substrate preferences was the same for both furin and DM. We are 
looking only at the amino acids (S2 subsite) which may be interacting with P2 
residue at substrate, but change in the overall conformation of substrate binding 
cleft may cause a different pattern of interaction with other amino acids (i.e., PI 
or PI ’) in the substrate.
w t  P A C E 4
D 9 0
C H
COO CH
COO
E 9 4 D
D9Q E94D
CH. CH
COO COO
D 9 0 T
D90T E 9 4
CH-,OH CH
CH CH
COO
DM
D90T E94D
CH^OH CH
c h 3 COO
Figure 5: The side chain of amino acids at 90 and 94th position in the S2 
subsite of wild type (wt) PACE4 and mutants (E94D, D90T and DM). Note 
that DM mimics furin residues at these positions.
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It is known that widely expressed SPCs are involved in many 
physiological and pathological functions. They are involved in processing many 
proteins like receptors, growth factors, hormones and neuropeptides, to their 
mature forms. In addition to processing cellular precursor proteins, SPCs are also 
involved in processing viral proteins and bacterial toxins. Thus, designing 
inhibitors is potentially very important. To design an inhibitor precise knowledge 
o f cleavage preferences of any individual enzyme is important. The cleavage 
preferences o f SPCs at the P2 residue have not been described in a level o f detail 
sufficient for designing specific inhibitors for individual SPCs. These results can 
provide preliminary data for designing specific inhibitors for individual SPCs.
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